Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Telmisartan/HCTZ FDC vs Monocomponents
NCT02187523Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1999
- Primary completion
- Dec 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Total area under concentration-time curve of the analytes in plasma from time zero to infinity, Maximum concentration of the analytes in plasma and 1 more. Started Oct 1999; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02187523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187523.